HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.06-7537comv1 21/8/1857    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dogra, C. Articles by Kumar, A. Search for Related Content PubMed PubMed Citation Articles by Dogra, C. Articles by Kumar, A.

TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine

Charu Dogra^*,1, Harish Changotra^*,1, Nia Wedhas^*,1, Xuezhong Qin^*,, Jon E. Wergedal^*, and Ashok Kumar^*,,,2

^* Musculoskeletal Disease Center,

Laboratory for Skeletal Muscle Physiology and Neurobiology, Jerry L. Pettis Memorial Veterans Administration Medical Center, Loma Linda, California, USA; and

Loma Linda University School of Medicine, Loma Linda, California, USA

²Correspondence: Laboratory for Skeletal Muscle Physiology and Neurobiology, Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton St. (151), Loma Linda, CA 92357, USA. E-mail: ashok.kumar2{at}va.gov

TWEAK cytokine has been implicated in several biological responses including inflammation, angiogenesis, and osteoclastogenesis. We have investigated the role of TWEAK in regulating skeletal muscle mass. Addition of soluble TWEAK protein to cultured myotubes reduced the mean myotube diameter and enhanced the degradation of specific muscle proteins such as CK and MyHCf. The effect of TWEAK on degradation of MyHCf was stronger than its structural homologue, TNF-. TWEAK increased the ubiquitination of MyHCf and the transcript levels of atrogin-1 and MuRF1 ubiquitin ligases. TWEAK inhibited phosphorylation of Akt kinase and its downstream targets GSK-3ß, FOXO1, mTOR, and p70S6K. Furthermore, TWEAK increased the activation of NF-B transcription factor in myotubes. Adenoviral-mediated overexpression of IBN (a degradation-resistant mutant of NF-B inhibitory protein IB) in myotubes blocked the TWEAK-induced degradation of MyHCf. Chronic administration of TWEAK in mice resulted in reduced body and skeletal muscle weight with an associated increase in the activity of ubiquitin-proteasome system and NF-B. Finally, muscle-specific transgenic overexpression of TWEAK decreased the body and skeletal muscle weight in mice. Collectively, our data suggest that TWEAK induces skeletal muscle atrophy through inhibition of the PI3K/Akt signaling pathway and activation of the ubiquitin-proteasome and NF-B systems.—Dogra, C., Changotra, H., Wedhas, N., Qin, X., Wergedal, J. E., Kumar, A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.

Key Words: skeletal muscle atrophy • atrogin-1 • MuRF1 • NF-B • Akt

This article has been cited by other articles:

				M. Sandri Signaling in Muscle Atrophy and Hypertrophy Physiology, June 1, 2008; 23(3): 160 - 170. [Abstract] [Full Text] [PDF]

				S. J. Crozier, M. D. Sans, C. H. Lang, L. G. D'Alecy, S. A. Ernst, and J. A. Williams CCK-induced pancreatic growth is not limited by mitogenic capacity in mice Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1148 - G1157. [Abstract] [Full Text] [PDF]

				A. K. Srivastava, X. Qin, N. Wedhas, M. Arnush, T. A. Linkhart, R. B. Chadwick, and A. Kumar Tumor Necrosis Factor-{alpha} Augments Matrix Metalloproteinase-9 Production in Skeletal Muscle Cells through the Activation of Transforming Growth Factor- -activated Kinase 1 (TAK1)-dependent Signaling Pathway J. Biol. Chem., November 30, 2007; 282(48): 35113 - 35124. [Abstract] [Full Text] [PDF]